Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies

Sorafenib is the first-line treatment of choice for advanced hepatocellular carcinoma (HCC). However, the benefits of sorafenib in HCC patients with portal vein tumour thrombosis (PVTT) remain uncertain. Until now, a total of eight comparative studies have been identified for this systematic review....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Prz Gastroenterol
Main Authors: Qi, Xingshun, Guo, Xiaozhong
Format: Artigo
Sprog:Inglês
Udgivet: Termedia Publishing House 2015
Fag:
Review Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607698/
https://ncbi.nlm.nih.gov/pubmed/26516379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2015.52470
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker